IDEXX LABORATORIES, INC.

(IDXX)
  Report
Delayed Nasdaq  -  05/18 04:00:01 pm EDT
357.33 USD   -2.46%
05/18IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
PR
05/13IDEXX LABORATORIES INC /DE : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/05JPMorgan Adjusts Price Target for IDEXX Laboratories to $625 From $725, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Sell: Idexx Laboratories

11/10/2021 | 05:38pm EDT


© MT Newswires 2021
All news about IDEXX LABORATORIES, INC.
05/18IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
PR
05/13IDEXX LABORATORIES INC /DE : Submission of Matters to a Vote of Security Holders (form 8-K..
AQ
05/05JPMorgan Adjusts Price Target for IDEXX Laboratories to $625 From $725, Maintains Overw..
MT
05/05Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $603 from $732, Keeps Overwe..
MT
05/05BofA Securities Downgrades IDEXX Laboratories to Neutral From Buy, Adjusts Price Target..
MT
05/04IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
05/04SECTOR UPDATE : Health Care Stocks Climb Pre-Bell Wednesday
MT
05/04TRANSCRIPT : IDEXX Laboratories, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04IDEXX Laboratories Q1 Earnings Slide, Revenue Rises; Company Lowers 2022 Outlook
MT
05/04IDEXX : Q1 Earnings Snapshot
AQ
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 447 M - -
Net income 2022 721 M - -
Net Debt 2022 817 M - -
P/E ratio 2022 42,5x
Yield 2022 -
Capitalization 30 018 M 30 018 M -
EV / Sales 2022 8,95x
EV / Sales 2023 7,99x
Nbr of Employees 10 350
Free-Float 77,9%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 357,33 $
Average target price 541,13 $
Spread / Average Target 51,4%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-45.73%30 018
ABBOTT LABORATORIES-19.89%197 401
MEDTRONIC PLC0.12%138 943
STRYKER CORPORATION-13.17%87 811
BECTON, DICKINSON AND COMPANY2.17%71 580
HOYA CORPORATION-25.01%36 535